Novo Integrated Sciences Shares Surge 70% After Company Secures $78M Funding From HSBC For Acquisition Of Ophir Collection
Novo Integrated Sciences Shares Surge 70% After Company Secures $78M Funding From HSBC For Acquisition Of Ophir Collection
Novo Integrated Sciences (NASDAQ:NVOS) surged 70.29% in after-hours trading to $0.77 following HSBC's confirmation of a $78 million Standby Letter of Credit.
汇丰银行确认了7800万美元的备用信用证后，Novo Integrated Sciences（纳斯达克股票代码：NVOS）在盘后交易中飙升70.29％，至0.77美元。
What Happened: Novo Integrated Sciences has confirmed receiving written confirmation from HSBC for a Ready, Willing, and Able (RWA) issued for the delivery of a Standby Letter of Credit via Swift MT 760, according to a company press release filed with the SEC.
发生了什么：Novo Integrated Sciences已确认收到汇丰银行对通过Swift MT 760交付备用信用证签发的Ready、Willing and Able（RWA）的书面确认， 根据 转到向美国证券交易委员会提交的公司新闻稿。
This move is part of a program aimed at monetizing the SBLC, which is projected to provide the company with gross funding proceeds of approximately $78 million by Jun. 14.
此举是旨在通过SBLC获利的计划的一部分，预计到6月14日，该计划将为该公司提供约7800万美元的总融资收益。
The proceeds are intended to secure the closing of a previously disclosed Purchase and Sale Agreement to acquire the Ophir Collection, granting Novo sole ownership of this collection.
所得款项旨在确保先前披露的收购Ophir Collection的收购和销售协议的完成，授予Novo对该藏品的唯一所有权。
The Ophir Collection refers to a specific collection of gemstones, with 43 gemstones in total, 42 of which are certified by the Gemological Institute of America.
Ophir 系列是指特定的宝石系列，共有 43 颗宝石，其中 42 颗获得了美国宝石研究所的认证。
Novo's CEO Robert Mattacchione anticipates generating surplus cash through the Ophir Collection program, supporting non-dilutive financing for the company's growth objectives amid funding challenges faced by micro-cap companies.
Novo首席执行官罗伯特·马塔基奥内预计，在微型股公司面临资金挑战的情况下，通过Ophir Collection计划产生盈余现金，为公司的增长目标提供非稀释性融资。
He said, "Our objective and focus on providing non-dilutive financing for the Company's growth objectives remains paramount. Specifically, both the Ophir Collection's monetizing potential together with the pending close of the previously disclosed $70 million SPA and Note with the RC Consulting Consortium Group, LLC will create the backstop necessary for the Company to pursue its' short and long-term global objectives."
他说：“我们的目标和重点仍然是为公司的增长目标提供非稀释性融资。具体而言，Ophir Collection的获利潜力，以及先前披露的与RC咨询联盟集团有限责任公司签订的7,000万美元SPA和票据的即将完成，都将为公司实现其短期和长期全球目标提供必要的支持。”
Novo Integrated Sciences focuses on patient-centric healthcare solutions, integrating medical technology, advanced therapeutics, and rehabilitative science. Their approach aims to decentralize healthcare, enhancing patient-practitioner interactions and potentially reducing on-site medical center visits.
Novo Integrated Sciences专注于以患者为中心的医疗保健解决方案，整合了医疗技术、先进疗法和康复科学。他们的方法旨在分散医疗保健，增强患者与从业者的互动，并可能减少现场医疗中心的就诊次数。
Price Action: NVOS closed at $0.45 on Thursday, showing a decrease of 0.84%. However, after hours, the stock surged to $0.77, marking an increase of 70.29%. Year to date, the stock has experienced a decrease of 41.43%, according to the data from Benzinga Pro.
价格走势：NVOS周四收于0.45美元，下跌0.84％。但是，盘后该股飙升至0.77美元，涨幅为70.29％。根据Benzinga Pro的数据，今年迄今为止，该股已下跌了41.43％。
Image Via Shutterstock
图片来自 Shutterstock
This story was generated using Benzinga Neuro and edited by Kaustubh Bagalkote
这个故事是使用 Benzinga Neuro 创作的，由 Kaustubh Bagalkote